Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Rollover Study in Chinese Patients After Finishing a 3-year Randomize Trial for Chronic Hepatitis B With High Serum Viral Load But Mild Elevated Aminotransferase

NCT02463019 is registered in ClinicalTrials.gov with E-DA Hospital as lead sponsor.

NCT NCT02463019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02463019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Rollover Study in Chinese Patients After Finishing a 3-year Randomize Trial for Chronic Hepatitis B With High Serum Viral Load But Mild Elevated Aminotransferase
Lead sponsor
E-DA Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2015
Completion date
January 31, 2020
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral treatment, chronic hepatitis b